Research programs

Progress is described one documented stage at a time.

The program map separates scientific direction from maturity. Only Research is active at launch; later stages require appropriate public evidence before they are shown as active.

Maturity sequence

01Research
02Prototype
03Validation
04Pilot
05Translation
06Commercial

Active stage: Research

Early Oncology Detection

A broader research direction focused on low-abundance molecular signals that may matter in early cancer and disease studies.

Research scope

Molecular recognition, rapid sensing, reproducible analytical workflows and responsible interpretation are studied together. Sensitivity alone is not treated as sufficient.

Public source record

Collaborator research2023

Using the body’s smallest clues to detect disease

Simon Fraser University

SFU overview of collaborator research on ultrasensitive, rapid cytokine sensors. It is contextual research and is not presented as Geno10X product performance.

Open original source

Background science2019

RNA detection with high specificity and sensitivity using nested fluorogenic Mango NASBA

RNA Journal

Peer-reviewed scientific context reporting 2.5 aM RNA detection, approximately 1.5 RNA molecules per microlitre, under the published experimental method. This is not presented as Geno10X product performance.

Open original source

Background science2022

Ultrasensitive rapid cytokine sensors based on asymmetric geometry two-dimensional MoS2 diodes

Nature Communications

Peer-reviewed background on an aptamer-functionalized rapid cytokine sensor. Its reported findings belong to that study, not to a Geno10X product.

Open original source

Active stage: Research

HPV & Cancer-Risk Research

The first public flagship program explores highly sensitive urine-based HPV detection, sensor science and AI-supported research analysis.

Research scope

Innovate BC records a C$300,000 Ignite collaboration. A separate NSERC record lists a C$225,000 sensor project. These are related but distinct public records.

Public source record

Geno10X collaboration2024

Innovate BC Awards $1.5M to Five Research & Development Projects Advancing Clean Tech and Life Sciences Solutions in British Columbia

Innovate BC

Official public announcement naming Geno10X Biosciences, Gene Bio Medical and Simon Fraser University researchers in an HPV point-of-care research collaboration, with a C$300,000 Ignite award.

Open original source

Public funding record2024

Development of sensor technology for ultrasensitive detection of HPV DNA

Natural Sciences and Engineering Research Council of Canada

Official NSERC funding record listing a separate C$225,000 Alliance project involving Simon Fraser University, Gene Bio Medical and Geno10X Biosciences.

Open original source

NEXT_PROGRAM: PENDING_PUBLIC_SCOPE

Future Detection Programs

Additional programs will be published only when an approved public description exists. A future direction will not be presented as active, validated or available before its scope and evidence can be stated accurately.